| The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease M Colom-Cadena, T Spires-Jones, H Zetterberg, K Blennow, A Caggiano, ... Alzheimer's research & therapy 12, 1-12, 2020 | 235 | 2020 |
| Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies M Colom-Cadena, E Gelpi, S Charif, O Belbin, R Blesa, MJ Martí, ... Journal of Neuropathology & Experimental Neurology 72 (12), 1203-1212, 2013 | 185 | 2013 |
| Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid A Lleó, R Núñez-Llaves, D Alcolea, C Chiva, D Balateu-Paños, ... Molecular & Cellular Proteomics 18 (3), 546-560, 2019 | 158 | 2019 |
| Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer’s disease EK Pickett, AG Herrmann, J McQueen, K Abt, O Dando, J Tulloch, P Jain, ... Cell reports 29 (11), 3592-3604. e5, 2019 | 150 | 2019 |
| PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins GT Corbett, Z Wang, W Hong, M Colom-Cadena, J Rose, M Liao, A Asfaw, ... Acta neuropathologica 139, 503-526, 2020 | 135 | 2020 |
| YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies M Querol-Vilaseca, M Colom-Cadena, J Pegueroles, ... Journal of neuroinflammation 14, 1-10, 2017 | 129 | 2017 |
| Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease M Pera, D Alcolea, R Sánchez-Valle, C Guardia-Laguarta, ... Acta Neuropathologica 125, 201-213, 2013 | 125 | 2013 |
| Synaptic phosphorylated α-synuclein in dementia with Lewy bodies M Colom-Cadena, J Pegueroles, AG Herrmann, CM Henstridge, L Munoz, ... Brain 140 (12), 3204-3214, 2017 | 104 | 2017 |
| Non-fibrillar oligomeric amyloid-β within synapses EK Pickett, RM Koffie, S Wegmann, CM Henstridge, AG Herrmann, ... Journal of Alzheimer's Disease 53 (3), 787-800, 2016 | 88 | 2016 |
| Regional overlap of pathologies in Lewy body disorders M Colom-Cadena, O Grau-Rivera, L Planellas, C Cerquera, E Morenas, ... Journal of Neuropatholgy & Experimental Neurology 76 (3), 216-224, 2017 | 76 | 2017 |
| Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype R Hesse, ML Hurtado, RJ Jackson, SL Eaton, AG Herrmann, ... Acta neuropathologica communications 7, 1-18, 2019 | 72 | 2019 |
| Nanoscale structure of amyloid-β plaques in Alzheimer’s disease M Querol-Vilaseca, M Colom-Cadena, J Pegueroles, R Nuñez-Llaves, ... Scientific reports 9 (1), 5181, 2019 | 66 | 2019 |
| MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies M Colom-Cadena, E Gelpi, MJ Martí, S Charif, O Dols-Icardo, R Blesa, ... Neurobiology of aging 34 (3), 936-942, 2013 | 58 | 2013 |
| Synaptic oligomeric tau in Alzheimer’s disease—a potential culprit in the spread of tau pathology through the brain M Colom-Cadena, C Davies, S Sirisi, JE Lee, EM Simzer, M Tzioras, ... Neuron 111 (14), 2170-2183. e6, 2023 | 48 | 2023 |
| Autosomal‐dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production M Suárez‐Calvet, O Belbin, M Pera, N Badiola, J Magrané, ... Journal of neurochemistry 128 (2), 330-339, 2014 | 48 | 2014 |
| Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease H Kurucu, M Colom‐Cadena, C Davies, L Wilkins, D King, J Rose, ... European Journal of Neurology 29 (5), 1311-1323, 2022 | 43 | 2022 |
| Proceedings from the fourth international symposium on σ-2 receptors: Role in health and disease NJ Izzo, M Colom-Cadena, AA Riad, J Xu, M Singh, C Abate, MA Cahill, ... eneuro 7 (6), 2020 | 24 | 2020 |
| Oligomers: a hot topic for neurodegeneration and a note of caution for experimental models E Gelpi, M Colom-Cadena Brain 142 (2), 228-230, 2019 | 9 | 2019 |
| Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model C Davies, J Tulloch, E Yip, L Currie, M Colom-Cadena, S Wegmann, ... Brain and Neuroscience Advances 7, 23982128231191046, 2023 | 8 | 2023 |
| Reducing voltage-dependent potassium channel Kv3. 4 levels ameliorates synapse loss in a mouse model of Alzheimer’s disease J Yeap, C Sathyaprakash, J Toombs, J Tulloch, C Scutariu, J Rose, K Burr, ... Brain and Neuroscience Advances 6, 23982128221086464, 2022 | 8 | 2022 |
